Antiadrenergic Drugs

42
ANTIADRENERG IC DRUGS By: Darya Osman Hussein Daoud Manal Bala Saeed

Transcript of Antiadrenergic Drugs

Page 1: Antiadrenergic Drugs

ANTIADRENERGIC DRUGS

By: Darya Osman Hussein DaoudManal Bala Saeed

Page 2: Antiadrenergic Drugs

The AdrenergicNeuron

• Synthesis and release of norepinephrine from the adrenergic neuron

• MOA – Monoamine Oxidase

• SNRI – Serotonin norepinephrine reuptake inhibitor

Page 3: Antiadrenergic Drugs

α Adrenergic Receptors (α Adrenoreceptors):Equally responsive to naturally occurring catecholamines (i.e. EP and NE)

Classified as α1 and α2

Page 4: Antiadrenergic Drugs

α1 Receptors:Present on postsynaptic membrane

Constrict smooth muscle

Activation initiates series of reaction through G protein

activation or phospholipase C

Ultimately results in generation of 2nd messengers IP3 (initiates

release of Ca2+ from ER into cytosol) and DAG (turns on other

proteins within the cell)

Page 5: Antiadrenergic Drugs

Present on sympathetic presynaptic nerve endings and parasympathetic presynaptic neurons

Controls release of NE via feedback inhibition

Also inhibits Ach release

Binding is mediated by inhibition of adenyl cyclase and fall in intracellular cAMP levels

α2 Receptors:

Page 6: Antiadrenergic Drugs

α Receptors

• DAG – diacylglycerol

• IP3 – Inositol 3 triphosphate

• ATP – Adenosine triphosphate

• cAMP – cyclic adenosine monophosphate

Page 7: Antiadrenergic Drugs

• Vasoconstriction• Increased peripheral resistance• Increase BP• Mydriasis• Increased closure of internal

sphincter of the bladderα1

• Inhibition of NE release• Inhibition of Ach release• Inhibition of insulin releaseα2

Page 8: Antiadrenergic Drugs

β Adrenergic Receptors (β Adrenoreceptors):Equally responsive to naturally occurring catecholamines (i.e. EP and NE)

Classified as β1, β2 and β3

Page 9: Antiadrenergic Drugs

β Adrenergic Receptors (β Adrenoreceptors):β1 have equal affinities to EP and NE

β2 have higher affinity for EP than for NE

β3 are responsible for lipolysis and have effects on detrusor muscle of the bladder

Binding results in activation of adenylyl cyclase and increased cAMP concentration

Page 10: Antiadrenergic Drugs

• Tachycardia• Increased lipolysis• Increased myocardial contractility• Increased release of reninβ1

• Vasodilation• Decreased peripheral resistance• Bronchodilation• Increased muscle and liver

glycogenolysis• Relaxed uterine smooth muscle

β2

Page 11: Antiadrenergic Drugs

Regulation:Desensitization of receptors can occur after prolonged exposure to catecholamines

Occurs via 1 of the following mechanisms:

1. Sequestration of receptors – become unavailable for interaction with ligand

2. Downregulation – disappearance of receptors by destruction or decreased synthesis

3. Phosphorylation - an inability to couple to G protein because of phosphorylation on cytoplasmic side

Page 12: Antiadrenergic Drugs

What are adrenergic antagonists?Drugs which antagonize the action of EP and NE at the receptor level

They occupy adrenergic receptors (α and β ) but do not produce signal transduction.

Can be reversible or irreversible

Classified according to relative affinity for α or β receptors

Page 13: Antiadrenergic Drugs
Page 14: Antiadrenergic Drugs

α adrenergic blockers

PHENOXYBENZAMINE, PHENTOLAMINE, PRAZOSIN, TERAZOSIN AND DOXAZOSIN

Page 15: Antiadrenergic Drugs

Phenoxybenzamine & Phentolamine

Page 16: Antiadrenergic Drugs

Non-selective α blockers

Actions: Block of α1 receptor

vasodilation and postural hypotension.

Block of α2 receptor

reduced NE action on α2 receptors on the varicosity

increases release of NE from varicosity which can cause

tachycardia and increased CO

Phenoxybenzamine & Phentolamine

Page 17: Antiadrenergic Drugs

Mechanism of action:

Binds covalently (and therefore irreversibly) to α receptor and blocks NA action.

Action is reversible in the case of phentolamine.

Phenoxybenzamine & Phentolamine

Page 18: Antiadrenergic Drugs

PharmacokineticsGiven orally, IV and SC injection.

T ½ for Phenoxybenzamine = 12 hours (because of irreversible binding to receptor).

T ½ for Phentolamine = 3 hours.

Phenoxybenzamine & Phentolamine

Page 19: Antiadrenergic Drugs

Clinical Use:Used in treatment of phaeochromocytoma

Adverse effects:Postural hypotension

Tachycardia

Dizziness and headache

Sexual disfunction

Phenoxybenzamine & Phentolamine

Page 20: Antiadrenergic Drugs

Prazosin, terazosin and doxazosin

Page 21: Antiadrenergic Drugs

Selective α1 antagonist

Action:Vasodilatation and reduction in BP.

Increase HR (a reflex β1 receptor resonse to the decrease in BP)

Decrease bladder sphincter tone.

Inhibition of hypertrophy on smooth muscle of bladder neck and prostate capsule.

Prazosin, terazosin and doxazosin

Page 22: Antiadrenergic Drugs

Mechanism of Action:

Block the action of endogenous and exogenous agonists on the α1 receptor.

Decrease peripheral vascular resistanceRelaxes arterial and venous smooth muscleCauses minimal changes in CO, renal blood flow and GFR

Prazosin, terazosin and doxazosin

Page 23: Antiadrenergic Drugs

Pharmacokinetics: Prazosin and Terazosin

absorbed orallyT ½ = 3 – 4 hoursMetabolised by liverExtensive 1st pass metabolism

DoxazosinT ½ = 22 hours

Prazosin, terazosin and doxazosin

Page 24: Antiadrenergic Drugs

Examples of uses of α1 selective blocker

Page 25: Antiadrenergic Drugs

Clinical use:

◦ Severe hypertension.◦ Benign prostatic hypertrophy.

Adverse effects:

◦ Orthostatic hypotension◦ Dizziness◦ Hypersensitivity reactions◦ Insomnia◦ Priapism

Prazosin, terazosin and doxazosin

Page 26: Antiadrenergic Drugs

Caution - SyncopeFirst dose of α1 receptor blocker may produce an orthostatic hypotensive response and result in fainting

Page 27: Antiadrenergic Drugs

β adrenergic blockers

PROPRANOLOL, TIMOLOL, NADOLOL, ACEBUTOLOL, ATENOLOL, METOPROLOL AND ESMOLOL

Page 28: Antiadrenergic Drugs

NON SELECTIVE

Propranolol Timolol Nadolol

Β1 SELECTIVE (CARDIOSELECTIVE)Acebutolol Atenolol Metoprolol Esmolol

β adrenergic blockers

Page 29: Antiadrenergic Drugs

PropranololNon – Selective β blocker

Action:CVS

decreases CO (-ve inotropic and chronotropic effects)Decreased SA and AV node activity

Peripheral vasoconstriction via increased peripheral resistance

Bronchoconstriction

Reduces renin release

Decreased glycogenolysis and glucagon secretion

Page 30: Antiadrenergic Drugs

Mechanism of Action:

Block sympathetic drive

Reducing pacemaker activity and increases AV conduction time

Reduces the slow inward Ca2+ current

Propranolol

Page 31: Antiadrenergic Drugs

Pharmacokinetics:

Orally administered

Almost completely absorbed

Extensive 1st pass metabolism (only 0.25 bioavailability)

Large volume of distribution

Readily crosses blood-brain barrier

Metabolites excreted in urine

Propranolol

Page 32: Antiadrenergic Drugs

Therapeutic uses:

Class II antiarrhythmicHypertensionAngina pectorisMigraineHyperthyroidism Prevention of death by dysrhythima following myocardial infarctionParoxymal atrial fibrillation

Propranolol

Page 33: Antiadrenergic Drugs

PropranololAdverse effects:Bronchoconstriction

Arrhythmias (if stopped abruptly)

Sexual impairment

Metabolic disturbances (fasting hypoglycemia)

CNS effects DissinessLethargy FatigueWeaknessVisual disturbancesHallucinationsShort term memory lossEmotiaonal labilityVivide dreamsDepression

Page 34: Antiadrenergic Drugs

Nadolol and TimololNon selective beta antagonists

Nadolol has very long duration of action

Action:Drecrease intraocular pressure

More potent than propranolol

Page 35: Antiadrenergic Drugs

Nadolol and Timolol Mechanism of action:

Reduce production of aqueous humor in the eye

Decrease secretion of aqueous humor by ciliary body

Do not cause cycloplesia

Page 36: Antiadrenergic Drugs

Nadolol and Timolol Pharmacokinetics:Onset is about 30 minutes when administered intraocularly

D.O.A. = 12 to 24 hrs

Clinical Use:Chronic management of glaucoma

Page 37: Antiadrenergic Drugs

Acebutolol, Atenolol, Bisoprolol, Esmolol, and MetoprololSlective beta blockers – known as cardioselective

Selectivity is lost at high doses

Action:Decrease BP in hypertension

Inrease exorcise tolerane in angina

Page 38: Antiadrenergic Drugs

Pharmacokinetics:

Orally administered

T ½ Atenolol = 6 hoursEsmolol = 10 hours

Acebutolol, Atenolol, Bisoprolol, Esmolol, and Metoprolol

Page 39: Antiadrenergic Drugs

Clinical Use:

Emergency treatment of supraventricular dysrhythmias (Esmolol)

Antianginal

Antihypertensive in diabetic patients reviecing insulin or oral

hypoglycemic agents

Acebutolol, Atenolol, Bisoprolol, Esmolol, and Metoprolol

Page 40: Antiadrenergic Drugs
Page 41: Antiadrenergic Drugs
Page 42: Antiadrenergic Drugs